A 28-year-old woman with newly diagnosed HIV (CD4 count 45 cells/μL) is being counseled on opportunistic infection prophylaxis. All of the following are appropriate prophylactic agents for her CD4 count EXCEPT:

Explanation

## OI Prophylaxis in Severe Immunosuppression (CD4 <50 cells/μL) ### Correct Prophylactic Indications (Options 0, 1, 2) **Key Point:** At CD4 <50 cells/μL, the patient requires prophylaxis against multiple opportunistic infections — the most aggressive tier of prevention. [cite:Harrison 21e Ch 197] | CD4 Count | Prophylaxis Indicated | Agent(s) | | --- | --- | --- | | <50 cells/μL | Cryptococcal meningitis | Fluconazole 200 mg daily | | <50 cells/μL | *Mycobacterium avium* complex | Azithromycin 1200 mg weekly | | <200 cells/μL | *Pneumocystis jirovecii* | TMP-SMX, dapsone, or pentamidine | | <100 cells/μL | *Toxoplasma gondii* | TMP-SMX (if CD4 <100) | **High-Yield:** Fluconazole at CD4 <50 is standard for cryptococcal prophylaxis. Azithromycin is indicated for MAC prophylaxis at CD4 <50. Dapsone is an acceptable alternative to TMP-SMX for PCP prophylaxis (especially in TMP-SMX-allergic patients). All three are appropriate at this CD4 level. [cite:Harrison 21e Ch 197] ### Why Option 3 Is Incorrect **Warning:** Rifabutin is NOT used for tuberculosis *prophylaxis* in HIV patients. It is reserved for **treatment of active TB** in co-infected patients. For TB prevention in a tuberculin skin test (TST)-positive, HIV-infected patient with CD4 <50 cells/μL: - **Isoniazid (INH)** is the agent of choice for TB prophylaxis (9 months) - Rifabutin is contraindicated as monotherapy for prevention (it selects for rifampicin resistance) - If active TB is present, rifabutin is used as part of a multi-drug regimen **Clinical Pearl:** The distinction is critical: TB *prophylaxis* = INH; TB *treatment* = multi-drug regimen including rifabutin or rifampicin. Using rifabutin alone for prevention is both ineffective and promotes drug resistance. [cite:Harrison 21e Ch 197] ### Prophylaxis Algorithm at CD4 <50 ```mermaid flowchart TD A[CD4 < 50 cells/μL]:::outcome --> B{Assess risk factors}:::decision B -->|TST positive| C[Isoniazid 9 months]:::action B -->|No TB risk| D[Continue MAC prophylaxis]:::action B -->|Cryptococcal risk| E[Fluconazole daily]:::action B -->|MAC risk| F[Azithromycin weekly]:::action C --> G[Recheck CD4 after ART]:::outcome D --> G E --> G F --> G ``` [cite:Harrison 21e Ch 197]